July 2016

Correspondence 
Response to: Where do you come from and what are you going to become, reactive astrocyte?
Maryam Faiz, Andras Nagy, Cindi M. Morshead
Stem Cell Investigation  
2016,  
3:
32  
Review Article 
Will targeting PI3K/Akt/mTOR signaling work in hematopoietic malignancies?
Yanan Gao, Chase Y. Yuan, Weiping Yuan
Stem Cell Investigation  
2016,  
3:
31  
Editorial 
eIF2α, a potential target for stem cell-based therapies
Ryo Fujita, Yusuke Ono
Stem Cell Investigation  
2016,  
3:
30  
Editorial 
Parentally imprinted genes regulate hematopoiesis—new evidence from the Dlk1–Gtl2 locus
Gabriela Schneider, Zachariah Payne Sellers, Mariusz Z. Ratajczak
Stem Cell Investigation  
2016,  
3:
29  
Editorial 
Bmi1-mediated epigenetic signature acts as a critical barrier for direct reprogramming to mature cardiomyocytes
Diego Herrero, Antonio Bernad
Stem Cell Investigation  
2016,  
3:
28  
Case Report 
Successful treatment of ibrutinib-associated central nervous system hemorrhage with platelet transfusion support
Karen Seiter, Michael F. Stiefel, Jacqueline Barrientos, Azfar Shaikh, Nasir Ahmed, Paul Baskind, Delong Liu
Stem Cell Investigation  
2016,  
3:
27  
Review Article 
Endothelial progenitor cells in hematologic malignancies
Ugo Testa, Ernestina Saulle, Germana Castelli, Elvira Pelosi
Stem Cell Investigation  
2016,  
3:
26